Neville J Butcher Selected Research

Reactive Oxygen Species (Oxygen Radicals)

1/2018

Arylamine N-acetyltransferase 1 protects against reactive oxygen species during glucose starvation: Role in the regulation of p53 stability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neville J Butcher Research Topics

Disease

21	Neoplasms (Cancer) 02/2024 - 05/2004
5	Breast Neoplasms (Breast Cancer) 10/2022 - 02/2010
3	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2013 - 09/2010
2	Prostatic Neoplasms (Prostate Cancer) 02/2011 - 01/2007
2	Spinal Dysraphism (Spina Bifida) 01/2011 - 01/2007
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2024
1	Metabolic Diseases (Metabolic Disease) 02/2024
1	Myocardial Infarction 12/2023
1	Body Weight (Weight, Body) 01/2023
1	Starvation 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Triple Negative Breast Neoplasms 04/2015
1	Schizophrenia (Dementia Praecox) 09/2010
1	Adenocarcinoma 02/2010
1	Endometriosis 06/2008

Drug/Important Bio-Agent (IBA)

13	N-acetyltransferase 1IBA 10/2022 - 05/2004
10	EnzymesIBA 02/2024 - 01/2007
5	Arylamine N-AcetyltransferaseIBA 02/2024 - 01/2007
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2012 - 01/2007
2	XenobioticsIBA 02/2024 - 01/2020
2	1-dodecylpyridoxal (PLD)IBA 01/2023 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 11/2019 - 05/2010
2	Messenger RNA (mRNA)IBA 11/2019 - 07/2018
2	Small Interfering RNA (siRNA)IBA 01/2018 - 04/2015
2	Cadherins (E-Cadherin)IBA 01/2018 - 02/2011
2	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 01/2011 - 09/2010
2	CarcinogensIBA 02/2010 - 01/2007
1	AcetyltransferasesIBA 02/2024
1	Acid Sensing Ion ChannelsIBA 12/2023
1	Monoclonal AntibodiesIBA 01/2023
1	Antipsychotic Agents (Antipsychotics)IBA 01/2023
1	InterferonsIBA 01/2023
1	LipidsIBA 01/2023
1	peginterferon alfa-2a (Pegasys)FDA Link 01/2023
1	N acetyltransferase deficiencyIBA 10/2022
1	Cytochromes c (Cytochrome c)IBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	N- (4- (N- (3- methoxypyrazin- 2- yl)sulfamoyl)phenyl)- 3- (5- nitrothiophene- 2- yl)acrylamideIBA 10/2022
1	Cisplatin (Platino)FDA LinkGeneric 10/2022
1	liposomal doxorubicin (Doxil)FDA Link 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Hypoxia-Inducible Factor 1IBA 11/2019
1	Metalloproteases (Metalloproteinases)IBA 11/2019
1	Matrix Metalloproteinases (MMPs)IBA 11/2019
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2019
1	Estrogen ReceptorsIBA 07/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Methionine (L-Methionine)FDA Link 02/2017
1	Dopamine (Intropin)FDA LinkGeneric 11/2013
1	monoamine-sulfating phenol sulfotransferaseIBA 11/2013
1	Environmental CarcinogensIBA 01/2012
1	theasinensin AIBA 01/2011
1	Histone Deacetylase InhibitorsIBA 01/2011
1	trichostatin A (A 300)IBA 01/2011
1	(Z)- 5- (2'- hydroxybenzylidene)- 2- thioxothiazolidin- 4- oneIBA 02/2010
1	N-acetyltalosaminuronic acid (NAT)IBA 06/2008
1	AndrogensIBA 01/2007

Therapy/Procedure

2	Therapeutics 01/2021 - 02/2011
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2012